(Q54561592)

1 June 2018

title

Captopril and hypertension development in the SHR. (English)

1 reference

1 June 2018

main subject

arterial hypertension

0 references

author name string

Giudicelli JF

1

1 reference

1 June 2018

Freslon JL

2

1 reference

1 June 2018

Glasson S

3

1 reference

1 June 2018

Richer C

4

1 reference

1 June 2018

publication date

1 January 1980

1 reference

1 June 2018

Clinical and Experimental Hypertension

published in

1 reference

1 June 2018

volume

2

1 reference

1 June 2018

issue

6

1 reference

1 June 2018

page(s)

1083-1096

1 reference

1 June 2018

Effects of chronic treatment with captopril (SQ 14,225), an orally active inhibitor of angiotensin I-converting enzyme, in spontaneously hypertensive rats

cites work

1 reference

https://api.crossref.org/works/10.3109%2F10641968009037162

Oral Angiotensin-Converting Enzyme Inhibitor in Long-Term Treatment of Hypertensive Patients

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10641968009037162

The effect of SQ14,225 on systolic blood pressure and urinary excretion of vasopressin in the developing spontaneously hypertensive rat

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10641968009037162

Development of left ventricular hypertrophy in young spontaneously hypertensive rats after peripheral sympathectomy

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10641968009037162

Prevention of the development of spontaneous hypertension in rats by captopril (SQ 14,225)

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10641968009037162

Antihypertensive Effect of the Oral Angiotensin Converting-Enzyme Inhibitor SQ 14225 in Man

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10641968009037162

Facilitation of adrenergic transmission by locally generated angiotensin II in rat mesenteric arteries

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10641968009037162

Effects of an Orally Active Converting-Enzyme Inhibitor, SQ 14225, on Pressor Responses to Angiotensin Administered into the Brain Ventricles of Spontaneously Hypertensive Rats

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10641968009037162

Measurement of renin activity, concentration and substrate in rat plasma by radioimmunoassay of angiotensin I.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10641968009037162

Selective activation of sympathetic ganglia in young spontaneously hypertensive rats

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10641968009037162

Design of Specific Inhibitors of Angiotensin-Converting Enzyme: New Class of Orally Active Antihypertensive Agents

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10641968009037162

Chronic antihypertensive effects of captopril (SQ 14,225), an orally active angiotensin I-converting enzyme inhibitor, in conscious 2-kidney renal hypertensive rats

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10641968009037162

Captopril (SQ 14,225) (d-3-mercapto-2-methylpropanoyl-l-proline): A novel orally active inhibitor of angiotensin-converting enzyme and antihypertensive agent

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10641968009037162

Mechanical and morphological properties of arterial resistance vessels in young and old spontaneously hypertensive rats

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10641968009037162

Sympathoadrenal medullary activity in young, spontaneously hypertensive rats

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10641968009037162

10.3109/10641968009037162

21 January 2018

Identifiers

DOI

1 reference

1 June 2018

PubMed ID

7004805

1 reference

1 June 2018